Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement and systemic lupus erythematosus.

David R Karp1

  • 1Rheumatic Diseases Division, The University of Texas Southwestern Medical Center at Dallas, 75390, USA. David.Karp@UTSouthwestern.edu

Current Opinion in Rheumatology
|August 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity.

Lupus science & medicine·2025
Same author

A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete Lupus.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

REDEFINING AUTOIMMUNE DISEASES: THE OPPORTUNITY FOR PRECISION AND PREVENTION.

Transactions of the American Clinical and Climatological Association·2025
Same author

Geographic Socioeconomic Influences on Disease Activity in Rheumatoid Arthritis in an Academic and Safety Net Hospital System.

ACR open rheumatology·2024
Same author

Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events.

JAMA network open·2023
Same author

Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.

Arthritis & rheumatology (Hoboken, N.J.)·2023
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

The complement system is crucial in systemic lupus erythematosus (SLE) pathogenesis. New research highlights its role in antiphospholipid syndrome and lupus nephritis, paving the way for targeted therapies.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathogenesis of Autoimmune Diseases

Background:

  • The complement system is integral to immune responses and implicated in systemic lupus erythematosus (SLE).
  • Activation of the classical complement pathway by immune complexes contributes to inflammation and tissue damage in SLE.
  • Complement activation influences self-antigen tolerance, a process often impaired in SLE.

Purpose of the Study:

  • To review recent advancements in understanding the complement system's role in SLE pathogenesis.
  • To elucidate the specific mechanisms by which complement contributes to SLE manifestations and progression.

Main Methods:

  • Review of current literature on complement pathways and SLE.
  • Analysis of findings from mouse models investigating antiphospholipid syndrome and lupus nephritis.

Related Experiment Videos

  • Examination of the molecular mechanisms linking complement activation to disease pathology.

    • Main Results:

    • Complement activation is essential for the prothrombotic effects in antiphospholipid syndrome, a key feature of SLE.
    • Heparin's protective effects in antiphospholipid syndrome models are attributed to anticomplementary, not anticoagulant, actions.
    • A mechanism for the association between anti-C1q autoantibodies and lupus nephritis has been identified in mouse models.

    Conclusions:

    • Recent findings solidify the critical role of complement in the development and tissue injury associated with SLE.
    • These insights support the development of targeted, mechanism-based therapies for SLE and other autoimmune inflammatory diseases.